Long-term outcome of convulsive status epilepticus: a 10-year follow-up

被引:3
|
作者
Kling, Rosa [1 ,2 ]
Ritvanen, Jaakko [1 ,2 ]
Mustonen, Harri [3 ,4 ]
Kamppi, Leena [5 ,6 ]
机构
[1] Univ Helsinki, Clin Neurosci, Neurol, Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland
[3] Univ Helsinki, Dept Surg, Helsinki, Finland
[4] Univ Helsinki, Cent Hosp, Helsinki, Finland
[5] Helsinki Univ Hosp, Dept Neurol, Epileps Helsinki, Helsinki, Finland
[6] Univ Helsinki, Helsinki, Finland
关键词
mortality; STESS; EMSE; cause of death; comorbidity; LIFE EXPECTANCY; CLINICAL SCORE; MORTALITY; PREDICTORS; STESS; EMSE; REFRACTORINESS; EPIDEMIOLOGY; MORBIDITY; PROGNOSIS;
D O I
10.1684/epd.2022.1482
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective. This study aimed to determine the mortality, causes of death and factors affecting the outcome of convulsive status epilepticus (CSE) at 10 years.Method. This retrospective study consisted of 62 consecutive adult patients diagnosed with CSE at the Helsinki University Hospital (HUS) emergency department during 2002-2003. Patients were followed for up to 10 years or up to the time of death. Data on patient demographics, CSE characteristics, treatment, complications, and outcome from the time of CSE were collected. The Official Statistics of Finland provided the information on mortality and causes of death. Survival analysis was conducted using Cox proportional hazards regression analysis.Results. In-hospital mortality was 8.1%, and mortality was 25.8% at one year, 51.6% at five years and 64.5% at 10 years. Estimated standardized mortality ratio (SMR) was 5.3 and the deceased patients lost 20.9 potential years of life, on average. The leading causes of death were disorders of the brain or the circulatory system, epilepsy-related conditions or intracranial tumours. The univariable survival analysis demonstrated that age >= 65 (HR=2.8, p=0.001), Charlson Comorbidity Index (CCI)>0 (CCI=1-3: HR=3.0, p=0.009; CCI>3: HR=8.4, p<0.001), Status Epilepticus Severity Score (STESS)>4 (HR=5.3, p<0.001) and Epidemiology-Based Mortality Score (EMSE-EAC)>15 (HR=2.2, p=0.036) were risk factors and a Glasgow outcome scale (GOS) of 5 at discharge (HR=0.14, p=0.025) was a protective factor for survival. The multivariable analysis established STESS>4 (HR=5.0, p=0.002) and CCI>0 (CCI=1-3: HR=2.9, p=0.015; CCI>3: HR=6.3, p=0.006) as independent risk factors and GOS>3 (time-dependent) (GOS=4: HR=0.33, p=0.048; GOS=5: HR=0.13, p=0.019) as a protective factor for survival.Significance. The rate of long-term mortality and number of potential years of life lost were high. Factors demonstrative of the overall situation of the patients, such as comorbidities, functional state after CSE and age, were significant predictors for long-term outcome.
引用
收藏
页码:1046 / 1059
页数:14
相关论文
共 50 条
  • [31] A 10-Year Follow-Up Study on Long-Term Clinical Outcomes of Lumbar Microendoscopic Discectomy
    Wang, M.
    Zhou, Y.
    Wang, J.
    Zhang, Z.
    Li, C.
    JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY, 2012, 73 (04) : 195 - 198
  • [32] Long-Term Outcomes on Pallidal Neurostimulation for Dystonia: A Controlled, Prospective 10-Year Follow-Up
    Krause, Patricia
    Mahlknecht, Philipp
    Skogseid, Inger Marie
    Steigerwald, Frank
    Deuschl, Guenther
    Erasmi, Richard
    Schnitzler, Alfons
    Warnecke, Tobias
    Mueller, Joerg
    Poewe, Werner
    Schneider, Gerd-Helge
    Vesper, Jan
    Warneke, Nils
    Eisner, Wilhelm
    Prokop, Thomas
    Mueller, Jan-Uwe
    Volkmann, Jens
    Kuehn, Andrea A.
    Deep-Brain Stimulation for Dystonia Study Grp
    MOVEMENT DISORDERS, 2025,
  • [33] 10-year experience of Paediatric varicocele embolization in a tertiary centre with long-term follow-up
    Wong, Simon
    Vigneswaran, Ganesh
    Maclean, Drew
    Bryant, Timothy
    Hacking, Nigel
    Maher, Ben
    Somani, Bhaskar
    Manoharan, Sengamalai
    Brownlee, Ewan
    Griffin, Stephen
    Modi, Sachin
    JOURNAL OF PEDIATRIC UROLOGY, 2022, 18 (02) : 113.e1 - 113.e6
  • [34] Onset Pattern and Long-Term Prognosis in Schizophrenia: 10-Year Longitudinal Follow-Up Study
    Kanahara, Nobuhisa
    Yoshida, Taisuke
    Oda, Yasunori
    Yamanaka, Hiroshi
    Moriyama, Toshihiro
    Hayashi, Hideaki
    Shibuya, Takayuki
    Nagaushi, Yasunori
    Sawa, Takashi
    Sekine, Yoshimoto
    Shimizu, Eiji
    Asano, Makoto
    Iyo, Masaomi
    PLOS ONE, 2013, 8 (06):
  • [35] Long-term treatment with doxazosin in men with benign prostatic hyperplasia: 10-year follow-up
    Dutkiewicz, Slawomir
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2004, 36 (02) : 169 - 173
  • [36] LONG-TERM COURSE OF BORDERLINE PERSONALITY DISORDER: A PROSPECTIVE 10-YEAR FOLLOW-UP STUDY
    Alvarez-Tomas, Irene
    Soler, Joaquim
    Bados, Arturo
    Martin-Blanco, Ana
    Elices, Matilde
    Carmona, Cristina
    Bauza, Joana
    Carlos Pascual, Juan
    JOURNAL OF PERSONALITY DISORDERS, 2017, 31 (05) : 590 - 605
  • [37] THE LONG-TERM RESULTS OF CHYMOPAPAIN - 10-YEAR FOLLOW-UP OF 268 PATIENTS AFTER CHEMONUCLEOLYSIS
    MACIUNAS, RJ
    ONOFRIO, BM
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1986, (206) : 37 - 41
  • [38] The long-term effectiveness of brief interventions for unsafe alcohol consumption: a 10-year follow-up
    Wutzke, SE
    Conigrave, KM
    Saunders, JB
    Hall, WD
    ADDICTION, 2002, 97 (06) : 665 - 675
  • [39] Long-term treatment with doxazosin in men with benign prostatic hyperplasia: 10-year follow-up
    Sławomir Dutkiewicz
    International Urology and Nephrology, 2004, 36 : 169 - 173
  • [40] 10-YEAR FOLLOW-UP
    MARKOWITZ, NR
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1979, 99 (02): : 177 - 177